Psychological stress in inflammatory bowel disease: Psychoneuroimmunological insights into bidirectional gut–brain communications

Inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn’s disease (CD), is an autoimmune gastrointestinal disease characterized by chronic inflammation and frequent recurrence. Accumulating evidence has confirmed that chronic psychological stress is considered to trigger...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 13; p. 1016578
Main Authors Ge, Li, Liu, Shuman, Li, Sha, Yang, Jing, Hu, Guangran, Xu, Changqing, Song, Wengang
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 06.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn’s disease (CD), is an autoimmune gastrointestinal disease characterized by chronic inflammation and frequent recurrence. Accumulating evidence has confirmed that chronic psychological stress is considered to trigger IBD deterioration and relapse. Moreover, studies have demonstrated that patients with IBD have a higher risk of developing symptoms of anxiety and depression than healthy individuals. However, the underlying mechanism of the link between psychological stress and IBD remains poorly understood. This review used a psychoneuroimmunology perspective to assess possible neuro-visceral integration, immune modulation, and crucial intestinal microbiome changes in IBD. Furthermore, the bidirectionality of the brain–gut axis was emphasized in the context, indicating that IBD pathophysiology increases the inflammatory response in the central nervous system and further contributes to anxiety- and depression-like behavioral comorbidities. This information will help accurately characterize the link between psychological stress and IBD disease activity. Additionally, the clinical application of functional brain imaging, microbiota-targeted treatment, psychotherapy and antidepressants should be considered during the treatment and diagnosis of IBD with behavioral comorbidities. This review elucidates the significance of more high-quality research combined with large clinical sample sizes and multiple diagnostic methods and psychotherapy, which may help to achieve personalized therapeutic strategies for IBD patients based on stress relief.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Edited by: Kevin P. Mollen, School of Medicine, University of Pittsburgh, United States
This article was submitted to Mucosal Immunity, a section of the journal Frontiers in Immunology
Reviewed by: Mikhail Melnikov, Federal Medical & Biological Agency of Russia, Russia; Hang Yu, China Academy of Chinese Medical Sciences, China
These authors have contributed equally to this work and share last authorship
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2022.1016578